Search

everythinglearnresearchcommunity

for

Search:↓

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Stem cells can move to brain injury sites and be tracked, showing promise for treating brain diseases.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Dual TCR Treg cells are common in mouse tissues and vary by location.

The glucocorticoid receptor helps protect skin from tumors and other issues.

Lgr6+ cells are important for tissue repair and could be a target for treating cancer and other diseases.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

MC-1R is present in skin cells and may help reduce inflammation.

Immune cells might contribute to hair loss caused by a specific mutation.

A patient's grey hair regained color during treatment with adalimumab.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Certain immune cells help hair growth by regulating iron in the skin.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-18 signaling helps mature Tregs move into the thymus.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata involves unique activation of certain immune cells.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Treg cells help repair and regenerate tissues by interacting with local cells.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.